Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Arcadia Wellness [Member]	January 2021 PIPE [Member]	June 2018 Warrants [Member]	May 2020 Warrant Transaction [Member]	May 2020 Warrants [Member]	Common Stock [Member]	Common Stock [Member] Arcadia Wellness [Member]	Common Stock [Member] January 2021 PIPE [Member]	Common Stock [Member] June 2018 Warrants [Member]	Additional Paid-In Capital [Member]	Additional Paid-In Capital [Member] Arcadia Wellness [Member]	Additional Paid-In Capital [Member] January 2021 PIPE [Member]	Additional Paid-In Capital [Member] June 2018 Warrants [Member]	Additional Paid-In Capital [Member] May 2020 Warrant Transaction [Member]	Additional Paid-In Capital [Member] May 2020 Warrants [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive (Loss) Income [Member]	Non-Controlling Interest [Member]
Stockholders Equity, Beginning Balance at Dec. 31, 2019	$ 8,326						$ 49				$ 214,826						$ (207,171)	$ 1	$ 621
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2019							8,646,149
Issuance of shares related to employee stock purchase plan	14										14
Issuance of shares related to employee stock purchase plan, Shares							7,946
Stock-based compensation	772										772
Unrealized losses on available-for-sale securities	(1)																	(1)
Non-controlling interest contributions	689																		689
Net income (loss)	2,423																2,525		(102)
Stockholders Equity, Ending Balance at Mar. 31, 2020	12,223						$ 49				215,612						(204,646)		1,208
Stockholders Equity, Ending Balance, Shares at Mar. 31, 2020							8,654,095
Stockholders Equity, Beginning Balance at Dec. 31, 2019	8,326						$ 49				214,826						(207,171)	1	621
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2019							8,646,149
Net income (loss)	(7,471)
Stockholders Equity, Ending Balance at Jun. 30, 2020	13,616						$ 50				226,405						(214,335)		1,496
Stockholders Equity, Ending Balance, Shares at Jun. 30, 2020							10,046,440
Stockholders Equity, Beginning Balance at Dec. 31, 2019	8,326						$ 49				214,826						(207,171)	1	621
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2019							8,646,149
Net income (loss)	(6,000)
Stockholders Equity, Ending Balance at Dec. 31, 2020	28,552						$ 54				239,496						(211,825)		827
Stockholders Equity, Ending Balance, Shares at Dec. 31, 2020							13,450,861
Stockholders Equity, Beginning Balance at Mar. 31, 2020	12,223						$ 49				215,612						(204,646)		1,208
Stockholders Equity, Beginning Balance, Shares at Mar. 31, 2020							8,654,095
Issuance of shares				$ 5,569						$ 1				$ 5,568
Issuance of shares, Shares										1,392,345
Issuance of investor warrants					$ 4,415										$ 4,415
Issuance of placement agent warrants						$ 215										$ 215
Stock-based compensation	595										595
Non-controlling interest contributions	493																		493
Net income (loss)	(9,894)																(9,689)		(205)
Stockholders Equity, Ending Balance at Jun. 30, 2020	13,616						$ 50				226,405						(214,335)		1,496
Stockholders Equity, Ending Balance, Shares at Jun. 30, 2020							10,046,440
Stockholders Equity, Beginning Balance at Dec. 31, 2020	28,552						$ 54				239,496						(211,825)		827
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2020							13,450,861
Issuance of shares			$ 15,516						$ 8				$ 15,508
Issuance of shares, Shares									7,876,784
Offering costs			(2,084)										(2,084)
Issuance of placement agent warrants			$ 942										$ 942
Issuance of shares related to employee stock purchase plan	21										21
Issuance of shares related to employee stock purchase plan, Shares							8,604
Non-controlling interest capital contribution	750																		750
Stock-based compensation	325										325
Net income (loss)	1,682																2,059		(377)
Stockholders Equity, Ending Balance at Mar. 31, 2021	45,705						$ 62				254,208						(209,766)		1,200
Stockholders Equity, Ending Balance, Shares at Mar. 31, 2021							21,336,249
Stockholders Equity, Beginning Balance at Dec. 31, 2020	28,552						$ 54				239,496						(211,825)		827
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2020							13,450,861
Foreign currency translation adjustment	(12)
Net income (loss)	(3,740)
Stockholders Equity, Ending Balance at Jun. 30, 2021	42,679						$ 63				256,616						(215,027)	(12)	1,039
Stockholders Equity, Ending Balance, Shares at Jun. 30, 2021							22,163,650
Stockholders Equity, Beginning Balance at Mar. 31, 2021	45,705						$ 62				254,208						(209,766)		1,200
Stockholders Equity, Beginning Balance, Shares at Mar. 31, 2021							21,336,249
Issuance of shares at closing of Arcadia Wellness acquisition		$ 2,053						$ 1				$ 2,052
Issuance of shares at closing of Arcadia Wellness acquisition, Shares								827,401
Foreign currency translation adjustment	(12)																	(12)
Stock-based compensation	356										356
Net income (loss)	(5,422)																(5,261)		(161)
Stockholders Equity, Ending Balance at Jun. 30, 2021	$ 42,679						$ 63				$ 256,616						$ (215,027)	$ (12)	$ 1,039
Stockholders Equity, Ending Balance, Shares at Jun. 30, 2021							22,163,650